期刊文献+

癌症免疫治疗临床新进展 被引量:1

Progress on Clinical Immunotherapy of Malignant Tumor
下载PDF
导出
摘要 肿瘤免疫治疗是一种利用患者自身免疫系统实现抗肿瘤作用的治疗方式,现已成为对抗肿瘤的新型有效疗法.然而,抑制性肿瘤微环境的存在可使肿瘤免疫治疗的效果大打折扣.本文将以肿瘤微环境的组成、分类及其对治疗效果的影响为出发点,探讨通过放化疗、免疫检查点、基因修饰免疫细胞以及多种联合治疗等方式应对抑制性肿瘤微环境,使免疫治疗发挥最大疗效. Tumor immunotherapy has now become a new effective therapy against cancer, as a way to use the patient's own immune system to achieve anti-tumor effect. However, the presence of inhibitory tumor microenvironment can greatly reduce the effect of immunotherapy. Base on the tumor microenvironment composition, classification and the effect of treatment, we explore ways to deal with the inhibition of tumor microenvironment through radiotherapy, chemotherapy, checkpoints, gene modified immune cells and combination therapy, to make the greatest effect of immunotherapy.
作者 陈运凡 洪娟 沈俊杰 钱程 CHEN Yun-Fan HONG Juan SHEN Jun-Jie QIAN Cheng(School of Life Science, Zhejiang Sci-Tech University, Hangzhou 310018, China Biotherapy Center, Southwest Hospital Affiliated to Third Military University, Chongqing 400038, China)
出处 《生物化学与生物物理进展》 SCIE CAS CSCD 北大核心 2017年第8期709-716,共8页 Progress In Biochemistry and Biophysics
基金 国家重点研发计划(2016YFC1303405)~~
关键词 肿瘤微环境 肿瘤免疫治疗 联合治疗 检查点抑制剂 CAR-T tumor microenvironment, cancer immunotherapy, combination therapy, checkpoint inhibitor, CAR-T
  • 相关文献

同被引文献11

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部